⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1937488 | 1.00 | — | — | |
| SCHEMBL2223474 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL222471 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL222472 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL222662 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL18547503 | 0.95 | — | — | |
| SCHEMBL1019673 | 0.84 | — | — | |
| SCHEMBL13632296 | 0.84 | — | — | |
| SCHEMBL12259738 | 0.84 | — | — | |
| SCHEMBL102903 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 551 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4261213-B1 | FGFR INHIBITOR COMPOUND AND USE THEREOF | SHENZHEN KANGSU PHARMACEUTICAL TECH CO LTD (CN) | 2026-04-15 | — | — | EP | claimed |
| EP-4071145-B1 | JAK INHIBITOR COMPOUND AND USE THEREOF | LU LIANG (CN) | 2025-01-08 | — | — | EP | claimed |
| EP-4472739-A1 | IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2024-12-11 | — | — | EP | claimed |
| CN-114981270-B | MLL1 inhibitors and anticancer agents | 诺华公司 | 2024-10-18 | — | — | CN | claimed |
| EP-3886845-B1 | NOVEL SUBSTITUTED PIPERAZINE AMIDE COMPOUNDS AS INDOLEAMINE 2, 3-DIOXYGENASE (IDO) INHIBITORS | MERCK SHARP & DOHME LLC (US) | 2024-09-04 | — | — | EP | claimed |
| CN-114127057-B | Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof | 德西费拉制药有限责任公司 | 2024-07-12 | — | — | CN | claimed |
| CN-118284602-A | Pyridine derivatives as sodium channel activators and uses thereof | 泽农医药公司 | 2024-07-02 | — | — | CN | claimed |
| CN-114222744-B | Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFNα response | 百时美施贵宝公司 | 2024-06-25 | — | — | CN | claimed |
| EP-4013756-B1 | MLL1 INHIBITORS AND ANTI-CANCER AGENTS | NOVARTIS AG (CH) | 2024-05-08 | — | — | EP | claimed |
| EP-3822273-B1 | SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS | INCYTE HOLDINGS CORP (US) | 2024-04-10 | — | — | EP | claimed |
| CN-105008362-B | Pyrrolo [2,3-D ] pyrimidine derivatives as janus-related kinase (JAK) inhibitors | 辉瑞大药厂 | 2017-06-06 | — | — | CN | claimed |
| CN-106459035-A | N2-phenyl-pyrido[3,4-d]pyrimidine-2,8-diamine derivatives and their use as mps1 inhibitors | 癌症研究科技有限公司 | 2017-02-22 | — | — | CN | claimed |
| EP-2576541-A1 | AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS | F.HOFFMANN-LA ROCHE AG (CH) | 2013-04-10 | — | — | EP | claimed |
| EP-2501691-A1 | SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES | F. Hoffmann-La Roche AG (CH) | 2012-09-26 | — | — | EP | claimed |
| WO-2011151360-A1 | AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2011-12-08 | — | — | WO | claimed |
| WO-2011073277-A1 | PIPERIDINE ARYL SULFONAMIDE DERIVATIVES AS Kv1.3 MODULATORS | EVOTEC AG (DE) | 2011-06-23 | — | — | WO | claimed |
| WO-2011061139-A1 | SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES | F. HOFFMANN-LA ROCHE AG (CH) | 2011-05-26 | — | — | WO | claimed |
| CN-101993404-A | Method for synthesizing N-Boc-3-pyrrolidine formaldehyde | ZHANPENG LIU | 2011-03-30 | — | — | CN | claimed |
| WO-1995001962-A1 | PROCESS FOR THE PREPARATION OF CHIRAL 3-(1-AMINO-1,1-BISALKYLMETHYL)-1-SUBSTITUTED-PYRROLIDINES | WARNER-LAMBERT COMPANY (US) | 1995-01-19 | — | — | WO | claimed |
| US-5347017-A | Process for chiral 3-(1-amino-1,1-bisalkylmethyl)-1-substituted-pyrrolidines | WARNER-LAMBERT COMPANY (US) | 1994-09-13 | — | — | US | claimed |